CAL
ORGS

Capital Advisors Ltd’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Capital Advisors Ltd’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85
Closed -$1K – 1694
2024
Q1 		$1K Buy
+85
New +$454 ﹤0.01% 1311

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Capital Advisors Ltd's ORGS Position: Q2 2024 in Review

Capital Advisors Ltd sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2024, closing a stake of 85 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in ORGS in Q1 2024 and held it in 1 quarter. The position peaked at $1K in Q1 2024. 18 funds tracked by Wall St. Rank hold ORGS as of Q2 2024.

  • Capital Advisors Ltd reported no remaining Orgenesis Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 85 Orgenesis Inc. Common Stock shares in Q2 2024, an estimated $1K.
  • Capital Advisors Ltd first reported a position in Orgenesis Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Capital Advisors Ltd's Orgenesis Inc. Common Stock position peaked at $1K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2024.

Based on Capital Advisors Ltd's 13F filing for Q2 2024, filed 25 Jul 2024.